Obesity Clinical Trials in Los Angeles

Showing 161-180 of 186 trials

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

NCT00402077

This study will examine the safety, tolerability, and body weight effect of subcutaneous pramlintide alone and in various combinations with the oral antiobesity agents sibutramine or phentermine in overweight and obese subjects.

OverweightObesity

AstraZeneca258 participantsStarted Nov 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Chula Vista, California, United States +13 more locations

WITHDRAWN< 1 mile

Clinical Utility of SUDOSCAN in the Pediatric Population

NCT02216201

The main purpose of this study is to evaluate whether SUDOSCAN is a valid, accurate clinical device for the the determination of sweat gland function in the pediatric population. Primary Objective: To measure sweat gland function in a pediatric population Secondary Objective: To determine thresholds on the SUDOSCAN scale for abnormal sweat gland function in the pediatric population

Childhood ObesityPrediabetesDiabetes

Impeto MedicalStarted Dec 2014

Los Angeles, California, United States

COMPLETED< 1 mile

A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-C

NCT00999661

The purpose of this study is to evaluate the results patients are obtaining with the Realize™ Adjustable Gastric Band-C during the first 24 months after surgery.

Morbid Obesity

Ethicon Endo-Surgery231 participantsStarted Nov 2009

Los Angeles, California, United States • Celebration, Florida, United States • Joliet, Illinois, United States +4 more locations

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Clinical Utility of SUDOSCAN in the Pediatric Population

A Study of Clinical Outcomes of the REALIZE Adjustable Gastric Band-C

Obesity Trials in Other Cities

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Guided Imagery Intervention for Obese Latino Adolescents

The Optimum Time for Preoxygenation Based on Body Mass Index

Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight Loss

The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study

Evaluation of California's SB 19 Pupil Nutrition Act

A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes

Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Weight Loss Study for People With Type 2 Diabetes

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients

A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects

Testing the Developmental Origins Hypothesis

Other Conditions in Los Angeles